Pharma Marketing in India

Authors

  •   P. K. Padhy Deptt. of Business Administration, Berhampur University
  •   S. C. Patnaik Marketing, National Institute Of Science and Technology, Berhampur

Abstract

In the recent years, Indian pharmaceutical market has exhibited 10% growth, as against 7% growth at the global level. However, there is a need to comply with WTO/IPR norms, and to bring in global standards by grabbing the huge potential of global pharmaceutical market. Indian firms have mostly English-speaking scientists and highly qualified and motivated young chemists, and have now faced stiff competition from Chinese firms which are producing world class pharmaceuticals at prices less than half as compared to the western countries. Further, mergers and acquisitions, liquidations and strategic alliances, and probably an attempt to create blockbuster brands for co- marketing of global pharmaceutical products will bring in newer opportunity for Indian talent pool of cheap skilled workers. Therefore, the Indian pharmaceutical companies must focus on their core competencies to produce world-class generics at highly competitive prices in order to capture the market share before Chinese grab it. The paper argues that it is possible only when Indian pharmaceutical companies seek to operate with highest efficiency and control the cost structure. This paper is an attempt to highlight the core competencies of successful Indian companies, and their capabilities to take leadership positions in global marketing of Pharmaceutical products, in the post- TRIPS era. For this, substantial investment in R & D is the need of the hour.

Downloads

Issue

Volume 1, Issue 2, July 2007

Section

Research and Academic Papers

License

It is herein agreed that:

1.I/We will not publish above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.

2.I/ We declare and warrant that the shared contribution is original, excerpts for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, proprietary right of others. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors.

3.The author also warrants that he/ she has the right to enter into this agreement, the research paper/ book review/ articlecontains no libelous or unlawful statements, contains no instructions that may cause harm or injury and does not violate the copyright or trademark, or infringes on the right or the privacy or others; and that all statements in the article asserted as facts are either true or are based upon reasonable research.

4.I/ We agree to indemnify the Editors of IMR against all claims and expenses arising from any breach of warranty from me/us in this agreement.